Suppressing miRNA-15a/-16 expression by interleukin-6 enhances drug-resistance in myeloma cells

<p>Abstract</p> <p>The bone marrow microenvironment facilitates the survival, differentiation, and proliferation of myeloma (MM) cells. This study identified that microRNA-15a and -16 expressions tightly correlated with proliferation and drug sensitivity of MM cells. miRNA-15a/-16...

Full description

Bibliographic Details
Main Authors: Chang Hong, Xu Yan, Zou Dehui, Yu Zhen, Sui Weiwei, Zhang Li, An Gang, Hao Mu, Qiu Lugui
Format: Article
Language:English
Published: BMC 2011-09-01
Series:Journal of Hematology & Oncology
Online Access:http://www.jhoonline.org/content/4/1/37
Description
Summary:<p>Abstract</p> <p>The bone marrow microenvironment facilitates the survival, differentiation, and proliferation of myeloma (MM) cells. This study identified that microRNA-15a and -16 expressions tightly correlated with proliferation and drug sensitivity of MM cells. miRNA-15a/-16 expression in MM cells was significantly increased after treatment with cytotoxic agents. The interaction of bone marrow stromal cells (BMSC) with MM cells resulted in decreased miRNA-15a/-16 expression and promoted the survival of the MM cells. Interleukin-6 (IL-6) produced by BMSCs suppressed the expression of miRNA-15a and 16 in a time- and dose- dependent pattern, with the suppression on miRNA-15a being more significant than on miRNA-16. miRNA-15a-transfected MM cells were found to be arrested in G1/S checkpoint, and the transfected MM cells had decreased growth and survival. In conclusion, our data suggest that via suppressing miRNA-15a and -16 expressions, IL-6 secreted by BMSCs promotes drug-resistance in myeloma cells.</p>
ISSN:1756-8722